Dentium CO., LTD Logo

Dentium CO., LTD

145720.KS

(2.0)
Stock Price

55.700,00 KRW

11.68% ROA

20.25% ROE

7.25x PER

Market Cap.

691.633.652.200,00 KRW

45.43% DER

0.5% Yield

23.14% NPM

Dentium CO., LTD Stock Analysis

Dentium CO., LTD Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Dentium CO., LTD Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (18.68%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 PBV

The stock's PBV ratio (2.65x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

4 DER

The stock maintains a fair debt to equity ratio (52%), indicating a reasonable balance between the money it owes and the ownership it possesses.

5 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

6 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (1.005.311) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

Dentium CO., LTD Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Dentium CO., LTD Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Dentium CO., LTD Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Dentium CO., LTD Revenue
Year Revenue Growth
2011 70.758.942.750
2012 61.976.635.650 -14.17%
2013 73.921.730.870 16.16%
2014 87.142.224.110 15.17%
2015 95.489.314.480 8.74%
2016 120.033.552.220 20.45%
2017 150.645.643.720 20.32%
2018 186.316.233.650 19.15%
2019 252.587.272.920 26.24%
2020 229.749.431.320 -9.94%
2021 291.529.687.470 21.19%
2022 355.865.975.040 18.08%
2023 375.107.796.000 5.13%
2023 393.188.581.139 4.6%
2024 446.688.838.476 11.98%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Dentium CO., LTD Research and Development Expenses
Year Research and Development Expenses Growth
2011 2.592.184.000
2012 2.168.430.000 -19.54%
2013 2.390.517.000 9.29%
2014 2.460.332.000 2.84%
2015 3.842.216.000 35.97%
2016 4.684.252.000 17.98%
2017 5.250.018.000 10.78%
2018 8.401.444.000 37.51%
2019 6.508.967.000 -29.07%
2020 5.016.345.000 -29.76%
2021 5.445.347.000 7.88%
2022 5.633.879.000 3.35%
2023 0 0%
2023 6.874.293.000 100%
2024 3.434.588.000 -100.15%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Dentium CO., LTD General and Administrative Expenses
Year General and Administrative Expenses Growth
2011 2.433.964.000
2012 2.506.509.000 2.89%
2013 3.191.776.000 21.47%
2014 4.719.695.000 32.37%
2015 5.374.642.000 12.19%
2016 6.101.181.000 11.91%
2017 7.307.695.000 16.51%
2018 11.063.818.000 33.95%
2019 15.457.297.000 28.42%
2020 10.747.153.000 -43.83%
2021 12.819.627.000 16.17%
2022 14.342.982.000 10.62%
2023 145.924.328.000 90.17%
2023 15.998.591.000 -812.11%
2024 161.374.004.000 90.09%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Dentium CO., LTD EBITDA
Year EBITDA Growth
2011 22.057.933.910
2012 12.516.032.500 -76.24%
2013 22.491.260.670 44.35%
2014 22.670.869.750 0.79%
2015 22.058.591.880 -2.78%
2016 31.344.099.100 29.62%
2017 41.599.749.130 24.65%
2018 49.424.539.480 15.83%
2019 58.233.245.790 15.13%
2020 49.842.035.980 -16.84%
2021 93.403.258.320 46.64%
2022 144.147.040.990 35.2%
2023 266.156.124.000 45.84%
2023 159.111.492.800 -67.28%
2024 133.220.997.720 -19.43%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Dentium CO., LTD Gross Profit
Year Gross Profit Growth
2011 51.170.258.530
2012 38.569.372.670 -32.67%
2013 56.495.353.070 31.73%
2014 61.512.372.600 8.16%
2015 68.712.446.100 10.48%
2016 83.288.427.340 17.5%
2017 106.618.514.170 21.88%
2018 130.771.448.310 18.47%
2019 167.579.668.700 21.96%
2020 142.797.046.530 -17.36%
2021 193.153.820.440 26.07%
2022 260.676.210.250 25.9%
2023 266.156.124.000 2.06%
2023 268.138.043.234 0.74%
2024 262.610.963.876 -2.1%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Dentium CO., LTD Net Profit
Year Net Profit Growth
2011 14.136.136.000
2012 7.410.915.890 -90.75%
2013 14.769.359.120 49.82%
2014 16.140.928.860 8.5%
2015 14.481.024.330 -11.46%
2016 19.793.092.310 26.84%
2017 30.066.434.810 34.17%
2018 34.253.295.530 12.22%
2019 14.785.641.220 -131.67%
2020 22.544.714.000 34.42%
2021 55.484.056.500 59.37%
2022 86.066.136.120 35.53%
2023 96.266.044.000 10.6%
2023 96.524.197.060 0.27%
2024 82.535.220.000 -16.95%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Dentium CO., LTD Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2011 1.458
2012 782 -86.45%
2013 1.874 58.27%
2014 2.507 25.25%
2015 2.383 -5.2%
2016 3.256 26.81%
2017 3.686 11.67%
2018 3.972 7.2%
2019 1.715 -131.74%
2020 2.614 34.43%
2021 6.434 59.37%
2022 9.980 35.53%
2023 11.163 10.6%
2023 11.192 0.27%
2024 9.571 -16.95%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Dentium CO., LTD Free Cashflow
Year Free Cashflow Growth
2011 -4.811.969.620
2012 12.907.114.500 137.28%
2013 8.102.570.630 -59.3%
2014 -11.467.868.110 170.65%
2015 -13.220.971.020 13.26%
2016 -1.394.004.920 -848.42%
2017 -51.376.536.110 97.29%
2018 -109.408.441.940 53.04%
2019 -64.081.378.170 -70.73%
2020 66.664.620.660 196.13%
2021 45.069.118.450 -47.92%
2022 -7.099.746.440 734.8%
2023 20.842.250.627 134.06%
2023 8.402.269.690 -148.06%
2024 -13.890.748.393 160.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Dentium CO., LTD Operating Cashflow
Year Operating Cashflow Growth
2011 2.346.839.480
2012 14.380.771.070 83.68%
2013 13.625.454.820 -5.54%
2014 6.162.926.170 -121.09%
2015 14.971.325.500 58.84%
2016 17.601.158.700 14.94%
2017 21.659.104.760 18.74%
2018 -574.593.400 3869.47%
2019 -11.642.097.630 95.06%
2020 75.754.918.140 115.37%
2021 74.111.673.800 -2.22%
2022 47.011.431.130 -57.65%
2023 64.988.760.003 27.66%
2023 19.937.497.050 -225.96%
2024 -5.991.664.026 432.75%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Dentium CO., LTD Capital Expenditure
Year Capital Expenditure Growth
2011 7.158.809.100
2012 1.473.656.570 -385.79%
2013 5.522.884.190 73.32%
2014 17.630.794.280 68.67%
2015 28.192.296.520 37.46%
2016 18.995.163.620 -48.42%
2017 73.035.640.870 73.99%
2018 108.833.848.540 32.89%
2019 52.439.280.540 -107.54%
2020 9.090.297.480 -476.87%
2021 29.042.555.350 68.7%
2022 54.111.177.570 46.33%
2023 44.146.509.376 -22.57%
2023 11.535.227.360 -282.71%
2024 7.899.084.367 -46.03%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Dentium CO., LTD Equity
Year Equity Growth
2011 39.496.027.200
2012 29.583.574.370 -33.51%
2013 43.835.634.020 32.51%
2014 42.354.341.090 -3.5%
2015 55.579.410.520 23.79%
2016 69.440.076.130 19.96%
2017 162.464.656.090 57.26%
2018 194.733.846.540 16.57%
2019 206.533.364.640 5.71%
2020 228.600.894.500 9.65%
2021 291.098.416.160 21.47%
2022 373.163.728.340 21.99%
2023 433.721.308.000 13.96%
2023 463.873.382.410 6.5%
2024 502.864.075.215 7.75%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Dentium CO., LTD Assets
Year Assets Growth
2011 78.726.157.230
2012 76.383.774.600 -3.07%
2013 83.618.726.110 8.65%
2014 116.279.771.650 28.09%
2015 148.492.294.950 21.69%
2016 187.358.424.020 20.74%
2017 310.870.929.140 39.73%
2018 436.826.577.080 28.83%
2019 547.106.597.710 20.16%
2020 510.235.858.600 -7.23%
2021 570.202.433.070 10.52%
2022 674.583.964.540 15.47%
2023 732.228.998.000 7.87%
2023 773.770.340.890 5.37%
2024 822.427.372.050 5.92%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Dentium CO., LTD Liabilities
Year Liabilities Growth
2011 39.230.129.880
2012 46.800.200.230 16.18%
2013 39.783.092.090 -17.64%
2014 73.925.430.710 46.18%
2015 92.912.884.340 20.44%
2016 117.918.347.890 21.21%
2017 148.406.273.050 20.54%
2018 242.092.730.540 38.7%
2019 340.573.233.070 28.92%
2020 281.634.964.100 -20.93%
2021 279.104.016.910 -0.91%
2022 301.420.236.200 7.4%
2023 298.507.690.000 -0.98%
2023 309.896.958.480 3.68%
2024 319.563.296.835 3.02%

Dentium CO., LTD Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
47820.03
Net Income per Share
11063.3
Price to Earning Ratio
7.25x
Price To Sales Ratio
1.68x
POCF Ratio
16.29
PFCF Ratio
56.39
Price to Book Ratio
1.37
EV to Sales
2.03
EV Over EBITDA
4.61
EV to Operating CashFlow
19.72
EV to FreeCashFlow
68.27
Earnings Yield
0.14
FreeCashFlow Yield
0.02
Market Cap
691,63 Bil.
Enterprise Value
837,32 Bil.
Graham Number
120617.29
Graham NetNet
-5549.13

Income Statement Metrics

Net Income per Share
11063.3
Income Quality
0.44
ROE
0.2
Return On Assets
0.12
Return On Capital Employed
0.23
Net Income per EBT
0.73
EBT Per Ebit
1.02
Ebit per Revenue
0.31
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.29
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.66
Operating Profit Margin
0.31
Pretax Profit Margin
0.32
Net Profit Margin
0.23

Dividends

Dividend Yield
0
Dividend Yield %
0.5
Payout Ratio
0.04
Dividend Per Share
400

Operating Metrics

Operating Cashflow per Share
4923.53
Free CashFlow per Share
1422.11
Capex to Operating CashFlow
0.71
Capex to Revenue
0.07
Capex to Depreciation
1.34
Return on Invested Capital
0.13
Return on Tangible Assets
0.12
Days Sales Outstanding
137.92
Days Payables Outstanding
25.59
Days of Inventory on Hand
353.08
Receivables Turnover
2.65
Payables Turnover
14.27
Inventory Turnover
1.03
Capex per Share
3501.41

Balance Sheet

Cash per Share
10.057,03
Book Value per Share
58.310,58
Tangible Book Value per Share
57642.75
Shareholders Equity per Share
58445.61
Interest Debt per Share
27087.19
Debt to Equity
0.45
Debt to Assets
0.28
Net Debt to EBITDA
0.8
Current Ratio
1.47
Tangible Asset Value
497,10 Bil.
Net Current Asset Value
66,86 Bil.
Invested Capital
467156170148
Working Capital
122,87 Bil.
Intangibles to Total Assets
0.01
Average Receivables
152,84 Bil.
Average Payables
9,89 Bil.
Average Inventory
137343879162.5
Debt to Market Cap
0.33

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Dentium CO., LTD Dividends
Year Dividends Growth
2017 150
2018 150 0%
2020 200 25%
2021 250 20%
2022 300 16.67%
2023 400 25%

Dentium CO., LTD Profile

About Dentium CO., LTD

Dentium Co.,Ltd. manufactures and sells dental implant products worldwide. Its dental implant systems include superline, implantium, simpleline II, slimline, overdenture system, NR line, and implantium II. The company also provides surgical instruments, such as surgical, drill stopper, sinus, osteotome, trephine bur, prosthetic, planning, restorative, and help kits, as well as harvest drills, sinus elevators, GBR systems, surgical guides, temporary shells, white seals, TN brushes, and guide systems; regeneration products, including bone grafts, membranes, and tissue regeneration products; and digital dentistry products. In addition, it offers lab products; and iCT motors and injections. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. The company was founded in 2000 and is headquartered in Seoul, South Korea.

CEO
Employee
792
Address
Dongsung Building
Seoul,

Dentium CO., LTD Executives & BODs

Dentium CO., LTD Executives & BODs
# Name Age

Dentium CO., LTD Competitors

Osstem Implant Co., Ltd. Logo
Osstem Implant Co., Ltd.

048260.KQ

(0.0)
Medy-Tox Inc. Logo
Medy-Tox Inc.

086900.KQ

(0.0)
Hugel, Inc. Logo
Hugel, Inc.

145020.KQ

()
AfreecaTV Co., Ltd. Logo
AfreecaTV Co., Ltd.

067160.KQ

(0.0)
Com2uS Corporation Logo
Com2uS Corporation

078340.KQ

(0.0)